Daiichi Sankyo and partner AstraZeneca have taken their HER2-targeted cancer drug Enhertu another step toward blockbusterland. The FDA cleared Enhertu for HER2-positive gastric or gastroesophageal...
Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild...
That didn’t take long. Fujifilm is laying plans for a new manufacturing facility in Watertown, Massachusetts—the second it’s announced in a little over a week....
At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients...
Billionaire investor Mark Cuban is famous for critiquing startup plans on the hit TV series “Shark Tank,” often dismissing would-be entrepreneurs with the show’s famous...
Catalent hustled to expand its manufacturing capacity last year as it juggled a surge of COVID-19 work with its regular production orders. That pandemic agenda caused problems in...
Sanofi has tied a name—and a new chief executive—to the European drug ingredients business it plans to spin off next year. Now dubbed EUROAPI, the active...